drug
as of 2026-07-01HS-10380
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Jiangsu Hansoh Pharmaceutical Co., Ltd.
2 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
2
Safety, Tolerability, Pharmacokinetics and Efficacy Study of HS-10380 in Patients With Schizophrenia
NCT05964790Phase 1, Phase 2Unknown
A Study of HS-10380 in Chinese Participants
NCT05480592Phase 1Unknown
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
indication
indication
indication